No Data
UNI HEALTH (02211.HK) reported interim earnings of 0.44 billion yuan, a decrease of 25.4% year-on-year.
Gelonghui, February 25丨UNI HEALTH (02211.HK) announced that for the six-month interim results ending December 31, 2024, the group recorded total revenue of 0.44 billion yuan, a decrease of 25.4% compared to the same period in 2023. The loss attributable to shareholders for the period was 8 million yuan, while the loss attributable to shareholders for the same period in 2023 was 20.9 million yuan. The loss per share during the period was 1.00 fen (for the six months ending December 31, 2023: 3.14 fen). The decrease in the loss attributable to shareholders was mainly due to the measures taken by the group.
Express News | Universal Health International Group Holding H1 Revenue RMB 441.2 Million
Express News | Universal Health International Group Holding H1 Gross Profit RMB 70.4 Million
UNI HEALTH: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 31 DECEMBER 2024
Universal Health International Group Holding Limited's (HKG:2211) Price Is Right But Growth Is Lacking After Shares Rocket 25%
UNI HEALTH (02211.HK) will hold a Board of Directors meeting on February 25 to approve the mid-term performance.
Gelonghui reported on February 13 that UNI HEALTH (02211.HK) announced that the Board of Directors will hold a meeting on February 25, 2025, to approve the interim results of the company and its subsidiaries for the six months ending December 31, 2024, and their release, as well as to consider the distribution of an interim dividend, if any.
